Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
| Image |  |
|---|---|
| Description | scientific article published on 31 January 2020 |
| Author/s |
author: Katja Weisel |
| Publication date | January 31, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |